Eva Maria Fenyö
1 – 50 of 73
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
Long-term follow-up of HIV-2-related AIDS and mortality in Guinea-Bissau : a prospective open cohort study
(
- Contribution to journal › Article
- 2014
-
Mark
Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition
(
- Contribution to journal › Article
-
Mark
Effect of HIV-2 infection on HIV-1 disease progression and mortality.
(
- Contribution to journal › Letter
-
Mark
Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals
(
- Contribution to journal › Article
-
Mark
Transmission HIV-2: Origin, Epidemiology, and Phenotype
2014) p.1-9(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2013
-
Mark
Effect of Complement on HIV-2 Plasma Antiviral Activity Is Intratype Specific and Potent
(
- Contribution to journal › Article
-
Mark
High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch
(
- Contribution to journal › Article
-
Mark
Frequent intratype neutralization by plasma immunoglobulin A identified in HIV-2 infection.
(
- Contribution to journal › Article
- 2012
-
Mark
International Network for Comparison of HIV Neutralization Assays: The NeutNet Report II
(
- Contribution to journal › Article
-
Mark
Potent Intratype Neutralizing Activity Distinguishes Human Immunodeficiency Virus Type 2 (HIV-2) from HIV-1
(
- Contribution to journal › Article
-
Mark
Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection.
(
- Contribution to journal › Article
- 2011
-
Mark
Reply to Redd et al
(
- Contribution to journal › Letter
-
Mark
Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm
(
- Contribution to journal › Article
-
Mark
Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge.
(
- Contribution to journal › Article
-
Mark
Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance.
(
- Contribution to journal › Article
- 2010
-
Mark
Enhanced CD4+cellular apoptosis by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with progressive HIV-1 infection
(
- Contribution to journal › Article
-
Mark
Serine- and Arginine-rich Proteins 55 and 75 (SRp55 and SRp75) Induce Production of HIV-1 vpr mRNA by Inhibiting the 5 '-Splice Site of Exon 3
(
- Contribution to journal › Article
-
Mark
Increased sensitivity to neutralizing antibodies of end-stage disease R5 HIV-1 is concomitant with reduced gp120 glycosylation and increased plus charge
(
- Contribution to journal › Published meeting abstract
-
Mark
Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
(
- Contribution to journal › Article
-
Mark
Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy.
(
- Contribution to journal › Article
-
Mark
Flexible use of CCR5 in the absence of CXCR4 use explains the immune deficiency in HIV-1 infected children.
(
- Contribution to journal › Article
-
Mark
High prevalence of HIV-1, HIV-2 and other sexually transmitted infections among women attending two sexual health clinics in Bissau, Guinea-Bissau, West Africa.
(
- Contribution to journal › Article
-
Mark
Microbial Translocation Correlates with the Severity of Both HIV-1 and HIV-2 Infections
(
- Contribution to journal › Article
-
Mark
Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease - indication of an evolving epidemic in West Africa
(
- Contribution to journal › Article
- 2009
-
Mark
Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells
(
- Contribution to journal › Article
-
Mark
Preserved cellular and humoral immune responses in macaques infected with SIVmac239 and subjected to early antiretroviral therapy
(
- Contribution to journal › Published meeting abstract
-
Mark
Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections
(
- Contribution to journal › Article
-
Mark
Comparison of HIV neutralization assays for use in vaccine research and clinical trials, phase II: results from the NeutNet working group
(
- Contribution to journal › Published meeting abstract
-
Mark
Broadly cross-neutralizing activity in plasma of HIV-1 and HIV-2 infected individuals
(
- Contribution to journal › Published meeting abstract
-
Mark
Differential Expression of the P-k Histo-Blood Group Antigen in Individuals with the Common P-1 and P-2 Phenotypes Predicts Susceptibility to HIV-1 Infection In Vitro
(
- Contribution to journal › Published meeting abstract
-
Mark
Prevalence and incidence of HIV-1 and HIV-2 before, during and after a civil war in an occupational cohort in Guinea-Bissau, West Africa.
(
- Contribution to journal › Article
-
Mark
International network for comparison of HIV neutralization assays: the NeutNet report.
(
- Contribution to journal › Article
- 2008
-
Mark
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination
(
- Contribution to journal › Scientific review
-
Mark
Sensitivity of HIV-1 primary isolates to human anti-CD40 antibody-mediated suppression is related to co-receptor use
(
- Contribution to journal › Article
-
Mark
Standardization of HIV Neutralization Assays for Use in Vaccine Research and Clinical Trials: Results from the NeutNet Working Group
(
- Contribution to journal › Published meeting abstract
-
Mark
Global HIV Vaccine Research Cryorepository - GHRC
(
- Contribution to journal › Published meeting abstract
-
Mark
Global HIV Vaccine Research Cryorepository - GHRC
(
- Contribution to journal › Published meeting abstract
-
Mark
Suppression of HIV replication in vitro by CpG and CpG conjugated to the non toxic B subunit of cholera toxin
(
- Contribution to journal › Article
-
Mark
Identification of a strongly activating human anti-CD40 antibody that suppresses HIV-1 infection
(
- Contribution to journal › Article
-
Mark
SIVmac239 is a potent immunogen for induction of neutralizing antibody response
(
- Contribution to journal › Published meeting abstract
-
Mark
SIVmac239 is a Potent Immunogen for the Induction of Neutralizing Antibody Response
(
- Contribution to journal › Published meeting abstract
-
Mark
Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge.
(
- Contribution to journal › Article
- 2007
-
Mark
Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression
(
- Contribution to journal › Article
-
Mark
Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998-1999.
(
- Contribution to journal › Article
-
Mark
Introduction: HIV neutralizing antibodies: relevance to pathogenesis and vaccines
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Frequent intrapatient recombination between HIV-1 R5 and X4 envelopes: Implications for coreceptor switch.
(
- Contribution to journal › Article
-
Mark
CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates
(
- Contribution to journal › Article
-
Mark
Asn 362 in gp120 contributes to enhanced fusogenicity by CCR5-restricted HIV-1 envelope glycoprotein variants from patients with AIDS
(
- Contribution to journal › Article
- 2006
-
Mark
Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome.
(
- Contribution to journal › Article